Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
67 patents granted to the 8 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Elanco Animal Health Incorporated’s names, not what it holds today.
Patents granted
67
67 utility, 1976 to Dec 31, 2025
Granted in 2025
12
Against 6 in 2024 and 6 in 2023
Applications published
69
15 of them in 2025
Names they are printed under
8
a subsidiary
By yearGrantedApplications published
'05'06'09'10'11'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals22
Food chemistry4
Biotechnology3
Organic fine chemistry3
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name8 counted
Elanco US Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
59 publishedElanco US Inc. a subsidiary
US, as the owner printed on each patent
41 granted
4 publishedElanco Tiergesundheit AG a subsidiary
CH, as the owner printed on each patent. 9 more under the same name are not counted (printed in US)
13 granted
0 publishedIvy Animal Health, Inc. a subsidiary
US, as the owner printed on each patent
4 granted
2 publishedLohmann Animal Health GmbH & Co. KG a subsidiary
DE, as the owner printed on each patent
3 granted
2 publishedVericore Limited a subsidiary
GB, as the owner printed on each patent
5 granted
0 publishedElanco UK AH Limited a subsidiary
named as the applicant on its applications, in GB
0 granted
2 publishedElanco UK AH Limited a subsidiary
GB, as the owner printed on each patent
1 granted
0 published
Names not counted (5)
Elanco Tiergesundheit AG
Most of its patents print US; this name counts in CH. 0 granted and 29 published under it are not counted.
Elanco Animal Health Inc
Most of its patents print DE; this name counts in US. 8 granted and 1 published under it are not counted.
Elanco Animal Health Inc
Most of its patents print DE; this name counts in US. 0 granted and 6 published under it are not counted.
Lohmann Animal Health GmbH
Most of its patents print US; this name counts in DE. 0 granted and 1 published under it are not counted.
Lohmann Animal Health GmbH
Most of its patents print US; this name counts in DE. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 16, 2025 | 12,497,370 | Isoxazoline derivatives | Organic fine chemistry | Elanco Tiergesundheit AG |
| Oct 21, 2025 | 12,448,438 | Anti-IL31 antibodies for veterinary use | Pharmaceuticals | Elanco US Inc. |
| Oct 21, 2025 | 12,448,391 | Bicyclic derivatives for treating endoparasites | Organic fine chemistry | Elanco Tiergesundheit AG |
| Oct 7, 2025 | 12,435,132 | Anti-IL31 antibodies for veterinary use | Pharmaceuticals | Elanco US Inc. |
| Sep 30, 2025 | 12,428,466 | IL4/IL13 receptor molecule for veterinary use | Pharmaceuticals | Elanco US Inc. |
| Aug 26, 2025 | 12,398,198 | Parvovirus antibodies for veterinary use | Pharmaceuticals | Elanco US Inc. |
| Aug 19, 2025 | 12,391,991 | Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease | Biotechnology | Elanco US Inc. |
| May 20, 2025 | 12,304,903 | Process for making an isoxazoline compound and intermediate thereof | Organic fine chemistry | Elanco US Inc. |
| Apr 29, 2025 | 12,286,462 | Porcine G-CSF variants and their uses | Pharmaceuticals | Elanco US Inc. |
| Feb 25, 2025 | 12,234,239 | Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile | Pharmaceuticals | Elanco US Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 13, 2025 | 2025/0345361 | COMPOSITIONS AND METHODS TO IMPROVE CALF GROWTH AND REDUCE INCIDENCE OF SCOURS | Food chemistry | Elanco US Inc. |
| Sep 11, 2025 | 2025/0281587 | VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND FELINE IL-1 BETA MUTEIN ANTIGENS | Pharmaceuticals | Elanco US Inc. |
| Sep 11, 2025 | 2025/0281586 | VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND CANINE IL-1 BETA MUTEIN ANTIGENS | Pharmaceuticals | Elanco US Inc. |
| Sep 11, 2025 | 2025/0281585 | VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND IL-1 BETA MUTEIN ANTIGENS | Pharmaceuticals | Elanco US Inc. |
| Aug 28, 2025 | 2025/0269006 | METHODS FOR PREDICTING EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINE | Pharmaceuticals | Elanco US Inc. |
| Aug 21, 2025 | 2025/0262276 | METHODS OF INHIBITING BOVINE MASTITIS DURING THE DRY PERIOD | Pharmaceuticals | Elanco US Inc. |
| Jul 3, 2025 | 2025/0215009 | PROCESS FOR MAKING CRYSTALLINE 2-(3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(CYCLOPROPYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE | Pharmaceuticals | Elanco US Inc. |
| Jun 19, 2025 | 2025/0195192 | WINGED CAPSULE DEVICES AND METHODS | Medical technology | Elanco US Inc. |
| May 22, 2025 | 2025/0161317 | MOLIDUSTAT FORMULATIONS AND METHODS OF USE FOR TREATMENT OF ANEMIA IN CATS | Pharmaceuticals | Elanco US Inc. |
| May 1, 2025 | 2025/0134960 | FORMULATIONS FOR BOVINE GRANULOCYTE COLONY STIMULATING FACTOR AND VARIANTS THEREOF | Pharmaceuticals | Elanco US Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 14 · Biotechnology 5 · Food chemistry 3 · Organic fine chemistry 2 · Basic materials chemistry 1 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.